Table 2. DSSP (Kabsch & Sander, 1983 ▸) assignment of secondary-structure elements in human muscle FBPase in the three states described in this work.
Gaps in the sequence (…) indicate fragments that were not modelled.
| Residue range | |||
|---|---|---|---|
| Secondary-structure element | R state | T state (−AMP) | T state (+AMP) |
| Allosteric domain | |||
| N-terminal | 8–10 | 11–12 | 8–12 |
| α1 | — | 13–19 | 13–23 |
| βα1 | 11–15 | — | — |
| L1 | 16–19…28 | 20…29 | 24–28 |
| α2 | 29–49 | 30–49 | 29–48 |
| L2 (catalytic loop) | 50–51…73 | 50…72 | 49–63…70 |
| αL2 | — | — | 53–56 |
| α3 | 74–87 | 73–86 | 71–86 |
| L3 | 88–90 | 87–90 | |
| β1 | 91–96 | ||
| L4 | 97–109 | 97–112 | 97–109 |
| βL4 | 103–104 | 99–104 | 103–104 |
| αL4 (310-helix) | 107–109 | ||
| β2 | 110–121 | 113–118 | 110–121 |
| L5 | 122…129–131 | 119–122…130–131 | 122–131 |
| αL5 (310-helix) | — | — | 123–128 |
| β3 | 132–140 | 132–139 | 132–140 |
| L6 | 141…147–160 | 140–158 | 141–142…147–160 |
| αL6a (310-helix) | 150–152 | 149–151 | 149–152 |
| αL6b (310-helix) | 156–158 | ||
| β4 | 161–167 | 159–167 | 161–167 |
| L7 | 168–170 | ||
| β5 | 171–176 | ||
| L8 | 177–181 | ||
| β6 | 182–187 | ||
| L9 | 188–191 | ||
| β7 | 192–197 | ||
| Catalytic domain | |||
| L10 | 198–207 | ||
| β8 | 208–210 | 208–209 | 208–210 |
| L11 | 211–220 | 210–220 | 211–220 |
| αL11 (310-helix) | 213–218 | 213–215 | 213–218 |
| α4 | 221–231 | ||
| L12 | 232–240 | ||
| β9 | 241–242 | ||
| L13 | 243–247 | ||
| α5 | 248–258 | ||
| L14 | 259–260 | ||
| β10 | 261–264 | ||
| L15 | 265–280 | ||
| α6 | 281–290 | ||
| L16 | 291–293 | ||
| β11 | 294–296 | ||
| L17 | 297–315 | ||
| αL17 (310-helix) | 302–304 | ||
| β12 | 316–319 | ||
| T1 | 320 | ||
| α7 | 321–332 | 321–335 | |
| C-terminal | 333–334 | 336–337 | 336–337 |